<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bayram F</submitter><funding>German Research Foundation</funding><funding>EU Horizon</funding><funding>German Cardiac Society</funding><funding>Else-Kröner-Fresenius Foundation</funding><funding>German Federal Ministry of Education and Research</funding><funding>German Heart Foundation (Deutsche Herzstiftung e.V.)</funding><pagination>163</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11851367</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(2)</volume><pubmed_abstract>Heart failure and cardiovascular disease represent a significant burden on healthcare systems worldwide. Recent evidence associates an increased expression of the dual-specificity tyrosine phosphorylation-regulated kinase 1B (DYRK1B) with an impaired cardiac function in mice. However, there remains a paucity of data on myocardial &lt;i>DYRK1B&lt;/i> expression in patients with cardiovascular disease in the context of other comorbidities. In our study, we examined &lt;i>DYRK1B&lt;/i> mRNA expression in human right atrial appendage biopsies from 159 patients undergoing elective coronary artery bypass surgery. Each patient was tested for sleep-disordered breathing the night prior to surgery. In this large representative study cohort with cardiovascular high-risk patients, we found that an impaired cardia</pubmed_abstract><journal>Antioxidants (Basel, Switzerland)</journal><pubmed_title>Myocardial &lt;i>DYRK1B&lt;/i> Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing.</pubmed_title><pmcid>PMC11851367</pmcid><funding_grant_id>Research Grant</funding_grant_id><funding_grant_id>doctoral network</funding_grant_id><funding_grant_id>LE 5009/3-1, project number: 528297116</funding_grant_id><funding_grant_id>project number: 2018_A159</funding_grant_id><funding_grant_id>TRR 374 grant (project number: 509149993, TPA6)</funding_grant_id><funding_grant_id>STRATIFY-HF (project number: 101080905)</funding_grant_id><funding_grant_id>Clinician Scientist Program</funding_grant_id><funding_grant_id>LE 5009/5-1, project number: 554804344</funding_grant_id><funding_grant_id>WA 2539/8-1</funding_grant_id><funding_grant_id>Heisenberg-Professorship (LE 5009/2-1, project number: 528296867)</funding_grant_id><funding_grant_id>project number: 01ZZ2324C</funding_grant_id><pubmed_authors>Tafelmeier M</pubmed_authors><pubmed_authors>Schmid C</pubmed_authors><pubmed_authors>Wermers D</pubmed_authors><pubmed_authors>Maier LS</pubmed_authors><pubmed_authors>Schildt S</pubmed_authors><pubmed_authors>Lebek S</pubmed_authors><pubmed_authors>Provaznik Z</pubmed_authors><pubmed_authors>Hegner P</pubmed_authors><pubmed_authors>Bayram F</pubmed_authors><pubmed_authors>Wagner S</pubmed_authors><pubmed_authors>Arzt M</pubmed_authors><pubmed_authors>Lauerer AM</pubmed_authors><pubmed_authors>Mustroph J</pubmed_authors><pubmed_authors>Baier MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myocardial &lt;i>DYRK1B&lt;/i> Expression Is Increased in Patients with Impaired Cardiac Contractility and Sleep-Disordered Breathing.</name><description>Heart failure and cardiovascular disease represent a significant burden on healthcare systems worldwide. Recent evidence associates an increased expression of the dual-specificity tyrosine phosphorylation-regulated kinase 1B (DYRK1B) with an impaired cardiac function in mice. However, there remains a paucity of data on myocardial &lt;i>DYRK1B&lt;/i> expression in patients with cardiovascular disease in the context of other comorbidities. In our study, we examined &lt;i>DYRK1B&lt;/i> mRNA expression in human right atrial appendage biopsies from 159 patients undergoing elective coronary artery bypass surgery. Each patient was tested for sleep-disordered breathing the night prior to surgery. In this large representative study cohort with cardiovascular high-risk patients, we found that an impaired cardia</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-18T12:47:32.192Z</modification><creation>2025-04-06T22:08:18.847Z</creation></dates><accession>S-EPMC11851367</accession><cross_references><pubmed>40002350</pubmed><doi>10.3390/antiox14020163</doi></cross_references></HashMap>